For Immediate Release: June 9, 2015
Medpace Founder, August Troendle, MD, Wins EY Entrepreneur Of The Year ® 2015 Award in Ohio Valley
CINCINNATI, OH – (June 9, 2015) – Medpace, on behalf of EY, is pleased to announce Dr. August Troendle as a winner of the EY Entrepreneur of the Year Award in the Ohio Valley region. Dr. Troendle joins a group of leading entrepreneurs – having been selected by an independent judging panel made up of previous winners of the award, leading CEOs, private capital investors and other regional business leaders. The winners were revealed at a special gala on June 4 at the Hyatt Regency in Cincinnati.
“EY has honored outstanding entrepreneurs for the past 29 years,” said Rich Mitchell, EY Entrepreneur Of The Year Program Director for Ohio Valley. “These winners are accomplished leaders who have contributed a tremendous amount to their communities”
Dr. August Troendle, a noted medical doctor and scientist in the study of lipid altering agents, saw an opportunity in 1992 to offer a more innovative way to conduct clinical trials on behalf of biopharmaceutical customers (sponsors). As a former Medical Review Officer with the FDA – Dr. Troendle’s personal achievements span both the scientific, regulatory, and the business arena. His vision for a physician-driven, full-service CRO with expertise in specific therapeutic areas spurred him on to found Medpace – capitalizing on an unmet need in the life science sector with a better way to design and deliver innovative process in clinical studies.
“The Medpace mission – to accelerate the global development of safe and effective medical therapeutics,” is key to our success,” said Dr. Troendle. “Medpace has enjoyed substantial organic growth. This continuous growth is a testimony to our continued focus on creating physician led clinical development for our sponsors through a more effective operational model.”
Founded and produced by EY, the Entrepreneur Of the Year Awards are nationally sponsored by the Ewing Marion Kauffman Foundation and SAP America.
Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across a number of therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and rare and orphan disease. With extensive medical expertise, and renowned regulatory affairs department, Medpace employs 1800 employees and has clinical trial experience in over 47 countries and 6 regions – North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. In addition, Medpace offers integrated imaging, central and bioanalytical lab capabilities, and clinical pharmacology through wholly owned business units to provide cohesive, streamlined, and standardized trial management. For more information visit the Medpace website at: www.medpace.com.
About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries.